Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) announced the launch of a generic equivalent of Epzicom®1 (abacavir and lamivudine) tablets, 600 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE